Literature DB >> 30893507

Embelin attenuates cisplatin-induced nephrotoxicity: Involving inhibition of oxidative stress and inflammation in addition with activation of Nrf-2/Ho-1 pathway.

Xuexiang Qin1, Kakani Meghana2, Nelluri Lakshmi Sowjanya2, Katakam Revathi Sushma2, Ch Gopala Krishna2, Jagarlamudi Manasa2, Gadamsetty Jaya Alekhya Sita2, Motati Gowthami2, Dronadula Honeyshmitha2, Gadiparthi Srikanth2, Nagaraja SreeHarsha3.   

Abstract

In kidneys, elevated levels of inflammatory cytokines and oxidative stress were observed in nephrotoxicity triggered by cisplatin. Embelin has the anti-inflammatory property. It also got anti-tumorigenic and antioxidant properties. In this research, we analyzed the actions of embelin on nephrotoxicity triggered by cisplatin and vital actions by which it increases antioxidant actions and corrects the inflammation after embelin administration during nephrotoxicity triggered by cisplatin. Kidney function markers including blood urea nitrogen; serum creatinine; the markers of oxidative stress like malondialdehyde (MDA), antioxidant systems like glutathione, superoxide dismutase, glutathione S-transferase, catalase, and glutathione reductase; inflammation markers like nuclear factor-κB (NF-κB), tumor necrosis factor-α (TNF-α), and interleukin-1 beta (IL-1β); and the extent of nuclear factor-erythroid-2 p45-related factor-2 (Nrf2) and heme oxygenase-1 (HO-1) were determined. Histopathology studies of kidneys were also used to analyze nephrotoxicity induced by cisplatin. Treatment with embelin (25 and 50 mg/kg) upgrades the function of kidneys, by elevating antioxidant levels and reducing the MDA level in cisplatin-administered rats. Embelin treatment demonstrated a significant curtailment of oxidative stress as well as increased the activities of antioxidant enzymes, endogenously. Cisplatin upregulates cytokines (i.e., TNF-α and IL-1β) and NF-κB, and downregulates Nrf2 and HO-1. Embelin treatment also reduced the infiltration of neutrophils in the renal tubules and thus reduced the level of histological impairment. The outcome of this study implements that the signaling pathway of Nrf2/HO-1 may be the principal mechanism of embelin for protection from nephrotoxicity triggered by cisplatin, and thus, embelin diminishes oxidative stress and inflammation by impeding NF-κB.
© 2019 BioFactors, 45(3):471-478, 2019. © 2019 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  cisplatin; embelin; inflammatory cytokines; nephrotoxicity; oxidative stress

Year:  2019        PMID: 30893507     DOI: 10.1002/biof.1502

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  5 in total

1.  Protection Against Post-resuscitation Acute Kidney Injury by N-Acetylcysteine via Activation of the Nrf2/HO-1 Pathway.

Authors:  Shiwei Wang; Guoxiang Liu; Tianyuan Jia; Changsheng Wang; Xiaoye Lu; Lei Tian; Qian Yang; Changqing Zhu
Journal:  Front Med (Lausanne)       Date:  2022-05-17

2.  Embelin as a Novel Inhibitor of PKC in the Prevention of Platelet Activation and Thrombus Formation.

Authors:  Jiun Yi Li; Ray Jade Chen; Li Ting Huang; Tzu Yin Lee; Wan Jung Lu; Kuan Hung Lin
Journal:  J Clin Med       Date:  2019-10-18       Impact factor: 4.241

3.  Sodium Tanshinone IIA Sulfonate Attenuates Tumor Oxidative Stress and Promotes Apoptosis in an Intermittent Hypoxia Mouse Model.

Authors:  Xiao-Bin Zhang; Xiao-Yang Chen; Peng Sun; Xiao-Man Su; Hui-Qing Zeng; Yi-Ming Zeng; Miao Wang; Xiongbiao Luo
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

4.  Antioxidant and Anti-Inflammatory Effects of 3-Dehydroxyceanothetric Acid 2-Methyl Ester Isolated from Ziziphus jujuba Mill. against Cisplatin-Induced Kidney Epithelial Cell Death.

Authors:  Dahae Lee; Kyo Bin Kang; Gwi Seo Hwang; You-Kyoung Choi; Tae Kon Kim; Ki Sung Kang
Journal:  Biomolecules       Date:  2021-10-31

Review 5.  Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity.

Authors:  Wen Gao; Lin Guo; Yan Yang; Yu Wang; Shuang Xia; Hui Gong; Bi-Kui Zhang; Miao Yan
Journal:  Front Cell Dev Biol       Date:  2022-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.